DBX1

Across TCGA pan-cancer cohorts, DBX1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DBX1 data layer compared with 19 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher DBX1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated DBX1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and GBM show a favorable association.

LUAD, CCRCC, and GBM are the cancer types where DBX1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.330	0.785	.002	18	view →
CCRCC	DFS	Quartile	All	0.802	0.263	.007	8	view →
GBM	DFS	Tertile	All	0.828	0.655	.013	7	view →
HNSC	DFS	Median	All	0.831	0.692	.026	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DBX1–LUAD (DFS)

Open the LUAD breakdown →